Literature DB >> 2425054

Proteolytic enzymes in experimental spinal cord injury.

N L Banik, E L Hogan, J M Powers, K P Smith.   

Abstract

Experimental spinal cord injury was produced in rats by dropping a 10 g weight from 30 cm upon dura-invested exposed spinal cord. Proteolytic activities at neutral (pH 7.6) and acid (pH 5.5 and 3.6) pH were determined in whole homogenate and the cytosolic fraction of the lesion (lumbar) and cervical control segments. The enzyme activity was monitored by SDS-PAGE analysis of the extent of substrate myelin basic protein (MBP) degradation. Activities (neutral and cathepsin B-like) in the sham-operated spinal cord were lower than those of cervical autologous control at 24 h after injury. The increase in neutral proteinase activity was progressive and greater in the lesion than the autologous control. A 61.5% +/- 3.5 loss of MBP was observed at 2 h following injury and increased at 24 h (78.2% +/- 3.4). The loss of MBP coincided with the appearance of several low molecular weight peptides. The cathepsin B-like and cathepsin D activities were also increased in the lesion but to a lesser extent than the neutral proteinase. The neutral proteinase and cathepsin B-like activity were inhibited by leupeptin and not by pepstatin while the converse obtained for cathepsin D activity. The release of neutral proteolytic activity which is nonlysosomal in origin suggests a novel hypothesis for the mechanism of traumatic axon-myelin injury.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2425054     DOI: 10.1016/0022-510x(86)90149-8

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  13 in total

1.  Sustained calpain inhibition improves locomotor function and tissue sparing following contusive spinal cord injury.

Authors:  Chen-Guang Yu; James W Geddes
Journal:  Neurochem Res       Date:  2007-05-03       Impact factor: 3.996

2.  Intraspinal MDL28170 microinjection improves functional and pathological outcome following spinal cord injury.

Authors:  Chen-Guang Yu; Aashish Joshi; James W Geddes
Journal:  J Neurotrauma       Date:  2008-07       Impact factor: 5.269

3.  Proteomic and phosphoproteomic analyses of the soluble fraction following acute spinal cord contusion in rats.

Authors:  Anshu Chen; Melanie L McEwen; Shixin Sun; Rangaswamyrao Ravikumar; Joe E Springer
Journal:  J Neurotrauma       Date:  2010-01       Impact factor: 5.269

4.  Ultrastructural evidence of axonal shearing as a result of lateral acceleration of the head in non-human primates.

Authors:  W L Maxwell; C Watt; D I Graham; T A Gennarelli
Journal:  Acta Neuropathol       Date:  1993       Impact factor: 17.088

5.  Role of calpain in spinal cord injury: increased calpain immunoreactivity in rat spinal cord after impact trauma.

Authors:  Z Li; E L Hogan; N L Banik
Journal:  Neurochem Res       Date:  1996-04       Impact factor: 3.996

Review 6.  Inhibition of cysteine proteases in acute and chronic spinal cord injury.

Authors:  Swapan K Ray; Supriti Samantaray; Joshua A Smith; Denise D Matzelle; Arabinda Das; Naren L Banik
Journal:  Neurotherapeutics       Date:  2011-04       Impact factor: 7.620

7.  Temporal profiles of cytoskeletal protein loss following traumatic axonal injury in mice.

Authors:  Gulyeter Serbest; Matthew F Burkhardt; Robert Siman; Ramesh Raghupathi; Kathryn E Saatman
Journal:  Neurochem Res       Date:  2007-03-31       Impact factor: 3.996

8.  An immunocytochemical study of calpain II in the hippocampus of rats injected with kainate.

Authors:  W Y Ong; L J Garey; K K Tan
Journal:  Exp Brain Res       Date:  1997-01       Impact factor: 1.972

9.  Myelopathy induced by lactic acid.

Authors:  J D Balentine; W B Greene
Journal:  Acta Neuropathol       Date:  1987       Impact factor: 17.088

10.  Stem cells downregulate the elevated levels of tissue plasminogen activator in rats after spinal cord injury.

Authors:  Krishna Kumar Veeravalli; Venkata Ramesh Dasari; Andrew J Tsung; Dzung H Dinh; Meena Gujrati; Dan Fassett; Jasti S Rao
Journal:  Neurochem Res       Date:  2009-01-17       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.